Article Versions Notes

Stroffolini G, De Nicolò A, Gaviraghi A, Mula J, Cariti G, Scabini S, Manca A, Cusato J, Corcione S, Bonora S, et al. Clinical Effectiveness and Pharmacokinetics of Dalbavancin in Treatment-Experienced Patients with Skin, Osteoarticular, or Vascular Infections. Pharmaceutics. 2022; 14(9):1882. https://doi.org/10.3390/pharmaceutics14091882

Stroffolini, Giacomo, Amedeo De Nicolò, Alberto Gaviraghi, Jacopo Mula, Giuseppe Cariti, Silvia Scabini, Alessandra Manca, Jessica Cusato, Silvia Corcione, Stefano Bonora, and et al. 2022. "Clinical Effectiveness and Pharmacokinetics of Dalbavancin in Treatment-Experienced Patients with Skin, Osteoarticular, or Vascular Infections" Pharmaceutics 14, no. 9: 1882. https://doi.org/10.3390/pharmaceutics14091882

Stroffolini, G., De Nicolò, A., Gaviraghi, A., Mula, J., Cariti, G., Scabini, S., Manca, A., Cusato, J., Corcione, S., Bonora, S., Di Perri, G., De Rosa, F. G., & D’Avolio, A. (2022). Clinical Effectiveness and Pharmacokinetics of Dalbavancin in Treatment-Experienced Patients with Skin, Osteoarticular, or Vascular Infections. Pharmaceutics, 14(9), 1882. https://doi.org/10.3390/pharmaceutics14091882